Skip to main content

Impact of the war in Ukraine on UEF

Syöpätutkimuksen seminaarin mainos

Cancer Research Seminar

  • Seminar
  • Health and well-being
Event date:
Event location:
Kuopio University Hospital, building M, 2nd floor, Auditorium 1, and online
Additional information:
Puijonlaaksontie 2
Add to calendar:

Cancer Research Seminar is organized by the Fican East scientific working group. Seminar is open for everyone interested in current cancer research at Fican East area. The attendance is free of charge. Welcome to join the seminar at Kuopio University Hospital or via Teams.  

Please register by 15 November. The link for participation to seminar via Teams will be send after registration. 


13.00-13.05     Opening of the seminar: Timo Nykopp 

Session 1: Short presentations of cancer research  


Aino Rönkä: IOPredict – Predictive Biomarkers of Cancer immune check point inhibition therapy 

Ville Paappanen: Efficiency of lung cancer care in Finland 

Otto Jokelainen: Hyaluronan and kidney cancer  

Mauro Scaravilli: RNA-binding proteins in oncogenic regulation of prostate cancer 

Heidi Kaljunen: Subclone eradication analysis identifies targets for enhanced cancer therapy and reveals L1 retrotransposition as a dynamic source of cancer heterogeneity. 

Stralina Eneh: Micro-RNAs in breast cancer 

Maarit Ahtiainen: Immune cell profiling in cancer  

Jouni Härkönen: Oncogenic redox signaling and tumor immunity  

14.15 – 14.35 Coffee break 

Session 2: Clinical Research 

14.35 - 14.50 Jan Seppälä: Advanced breast cancer radiotherapy in KUH

14.50 -15.05 Stefan Becker: ALLTogether: toward individualized treatment for childhood ALL 

15.05-15.20 Merja Heinäniemi: Deep genomic characterization of early treatment response in pediatric acute lymphoblastic leukemia  

15.20-15.35 Teijo Kuopio: Local experiences in the application and development of molecular pathology research data and methods for clinical patient work 

15.35-15.50 Juha Väyrynen: Multiplex immunohistochemistry for cancer reasearch and personalized medicine

15.50 -16.15 Discussion 

For more information, please contact Research Coordinator Maarit Sillanpää, email